After breaking a three-month losing streak with a 1% gain in June and then retreating almost 10% in July, the Canadian Cannabis LP Index fell sharply again in August, declining 7.5%...
The Canadian Cannabis LP Index broke a three-month losing streak in June, increasing 1.2% to 359.27. The index, which rallied 22.1% in Q4 but still fell 30.1% in 2020 to...
The Canadian Cannabis LP Index fell for the third consecutive month in May, declining 3.9% to 354.97. but it also rallied 9.3% off the May 13th close of 324.84, the...
The Canadian Cannabis LP Index pulled back slightly in April, its second straight decline after a strong first two months to begin the year, declining 4.9% to 369.45: The index, which...
The Canadian Cannabis LP Index pulled back slightly in March after a strong first two months to begin the year, declining 6.3% to 388.44: The index, which rallied 22.1% in Q4...
The Canadian Cannabis LP Index built upon its 27% increase in January, advancing 18.8% in February to 414.46 despite a substantial pullback from its peak on February 10th: The index, which...
The Canadian Cannabis LP Index started 2021 strongly, advancing 26.7% to 348.75: The index, which rallied 22.1% in Q4 but still fell 30.1% in 2020, is down 8.6% over the past...
The Canadian Cannabis LP Index continued to lag the broader sector in December, retreating 4.8% to 275.16: The index, which rallied 22.1% in Q4, still fell 30.1% in 2020: It remains...
While the Canadian Cannabis LP Index continued to lag the broader sector, it posted strong gains in November as it increased 23.6% to 288.97: The index, which closed at a four-month high,...
While the Canadian Cannabis LP Index lagged the broader sector, it was able to snap a two-month losing streak in October as it gained 3.7% to 233.78: The index, which lost 20.3%...
After losing almost 7% in August, the Canadian Cannabis LP Index continued to struggle in September, losing 15.4% to 225.41: During Q3, the index fell by 20.3%. Over the past year, it...
VIVO Cannabis™ Announces Agreement to Amend Outstanding Debentures TORONTO, Sept. 16, 2020 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO) (“VIVO” or the “Company”) announces that the holders of its 6% unsecured convertible debentures dated February...
Canadian licensed producers, which rose in both April and May after twelve consecutive monthly declines through March, reversed some of the recent gains, with the Canadian Cannabis LP Index declining 11.4%...
Canadian licensed producers, after twelve consecutive monthly declines through March, posted their second straight gain during May, with the Canadian Cannabis LP Index rising 20.2% to 319.23, far surpassing the performance...
Canadian licensed producers finally broke a twelve-month streak of monthly declines during April, with the Canadian Cannabis LP Index rising 7.6% to 265.65, slightly lagging the S&P/TSX Composite, which rose 10.5%:...
Canadian licensed producers experienced their twelfth consecutive monthly decline during March, with the Canadian Cannabis LP Index falling 18.3% to 246.96, slightly worse than the S&P/TSX Composite, which fell 17.7%: Over...
Canadian licensed producers experienced their eleventh consecutive monthly decline during February, with the Canadian Cannabis LP Index falling 20.8% to 302.23: Over the past year, the index has declined 69.7%: The...
Canadian licensed producers experienced their tenth consecutive monthly decline during January, with the Canadian Cannabis LP Index falling 3.1% to 381.71: The index remains substantially below the all-time closing high of 1314.33...
NAPANEE, ON, Dec. 20, 2019 /CNW/ – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today officially revealed its new Cannabis 2.0. products set to come...
Canadian licensed producers experienced another rough month in November, with the Canadian Cannabis LP Index falling 16.0% to 404.94, the eighth consecutive monthly loss: The index remains substantially below the all-time...
VIVO Cannabis™ Reports Third Quarter 2019 Results Net revenue was $6.3 million in the quarter, a 19% increase, quarter-over-quarter, and 175% increase over Q3 2018, and $16.6 million year-to-date,...
NAPANEE, ON, Nov. 12, 2019 /CNW/ – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange...
Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research capabilities Joint venture will...
Announcements made during VIVO’s Analyst and Investor Day Held at Napanee Operations NAPANEE, ON, Oct. 3, 2019 /CNW/ – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced it expects...
VIVO Cannabis™ Partners with Linneo Health to Supply Medical Cannabis in Europe Linneo Health Receives EU-GMP Certification NAPANEE, ON, Sept. 17, 2019 /CNW/ – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or...
